|
Boston Business Journal Online and Daily Newsletter Solace Pharmaceuticals Inc. in Boston announced the news on Tuesday. Polaris Venture Partners and Interwest Partners led the round, which also included existing investors and co-founder PureTech Ventures. The company also announced it has hired a CEO -- Eliot Forster, who worked most recently for Pfizer as head of development in Europe and Asia. Solace will focus on treating the causes of both chronic neuropathic and inflammatory pain. Its founders include a number of pain experts based at Harvard Medical School and Massachusetts General Hospital. Story also ran on MSNMoney: http://news.moneycentral.msn.com |
Latest NewsSolace's Chemistry Advisory Board members featured05 February 2008 Solace Pharmaceuticals names two new senior team members 04 February 2008 Emerging Company Profile - Solace: Comfort in (Pain) Research, BioCentury 09 July 2007 Solace ready to go global in two continents with $15M in VC, to begin treatment tests for chronic pain 25 May 2007 Solace Pharmaceuticals (Boston) - Eliot Forster was named chief executive with this developer of therapeutics .. 05 May 2007 Start-Up Solace Raises $15M In Series A For Pain Drugs 02 May 2007 Solace Pharmaceuticals Raises $15M in Series A Financing; Names Senior Pfizer Executive as CEO 01 May 2007 Pain Gain: Drug startup developing new approach to chronic pain 01 May 2007 Solace Pharmaceuticals launches with $15M in VC 01 May 2007 Solace Pharma raises $15m 01 May 2007 Solace Raises $15M For New Pain Treatments 01 May 2007 Solace raises $15 million, names CEO 01 May 2007 |